IPO Calendar
Upcoming IPOs with underwriters, number of shares, offering price, and timing of the offering. See times when analysts are allowed to rate stocks and when company employees can not sell their stocks after an IPO.
Updated: 05-May-26 09:09 ET
Ends: 11-May-26 | Co: ARXS
Arxis (Nasdaq) | Designs and manufactures specialized electronic and mechanical components for aerospace, defense, medical, and industrial markets, delivering high-performance, mission-critical solutions | Opened: 16-Apr-26, $38.00 | Priced: $28.00 | Underwriters: Lead: Goldman Sachs & Co. LLC, Morgan Stanley and Jefferies |
Ends: 11-May-26 | Co: MAIR
Madison Air (NYSE) | Operates a portfolio of air quality brands, delivering innovative solutions for safer, healthier, and more efficient indoor environments in both commercial and residential spaces | Opened: 16-Apr-26, $32.00 | Priced: $27.00 | Underwriters: Lead: Goldman Sachs & Co. LLC, Barclays, Jefferies and Wells Fargo Securities |
Ends: 12-May-26 | Co: ALMR
Alamar Biosciences (Nasdaq) | Life sciences company developing ultra-sensitive proteomics technologies, including its NULISA platform and ARGO HT system, to enable earlier disease detection | Opened: 17-Apr-26, $22.60 | Priced: $17.00 | Underwriters: Lead: JP Morgan, BofA Securities, and TD Cowen |
Ends: 12-May-26 | Co: AVEX
AEVEX Corp. (NYSE) | Defense technology company providing unmanned systems, loitering munitions, and aircraft modification services for U.S. and allied missions | Opened: 17-Apr-26, $23.01 | Priced: $20.00 | Underwriters: Lead: Goldman Sachs & Co. LLC, BofA Securities and Jefferies |
Ends: 12-May-26 | Co: KLRA
Kailera Therapeutics (Nasdaq) | Phase 3 biotech developing injectable and oral GLP-1–based therapies for obesity, led by its Phase 3 dual agonist candidate ribupatide | Opened: 17-Apr-26, $26.00 | Priced: $16.00 | Underwriters: Lead: JP Morgan, Jefferies, Leerink Partners, TD Cowen, and Evercore ISI |
Ends: 18-May-26 | Co: ELMT
The Elmet Group Co. (Nasdaq) | U.S.-based manufacturer of precision-engineered components and high-power microwave systems serving aerospace, defense, semiconductor, and other advanced industries | Opened: 23-Apr-26, $18.00 | Priced: $14.00 | Underwriters: Lead: Cantor Fitzgerald & Co. |
Ends: 18-May-26 | Co: NHP
National Healthcare Properties | REIT focused on acquiring a diversified portfolio of healthcare real estate, with an emphasis on senior housing and outpatient medical facilities located in the U.S. | Opened: 22-Apr-26, $11.56 | Priced: $12.00 | Underwriters: Lead: Wells Fargo Securities, Morgan Stanley and BMO Capital Markets |
Ends: 18-May-26 | Co: YSWY
Yesway (Nasdaq) | U.S. convenience store operator known for its food offerings and private-label products, with hundreds of locations across the Midwest and Southwest | Opened: 22-Apr-26, $22.00 | Priced: $20.00 | Underwriters: Lead: Morgan Stanley |
Ends: 19-May-26 | Co: XE
X-Energy (Nasdaq) | Developer of advanced small modular nuclear reactors and fuel for clean energy | Opened: 24-Apr-26, $30.11 | Priced: $23.00 | Underwriters: Lead: J.P. Morgan, Morgan Stanley, Jefferies, and Moelis & Company |
Ends: 25-May-26 | Co: AVLN
Avalyn Pharma (Nasdaq) | Clinical-stage biotech developing inhaled therapies to improve treatment of rare lung diseases like pulmonary fibrosis | Opened: 30-Apr-26, $26.00 | Priced: $18.00 | Underwriters: Lead: Morgan Stanley, Jefferies, Evercore ISI, Guggenheim Securities |
Ends: 25-May-26 | Co: PS
Pershing Square (NYSE) | Alternative asset management firm owned by Bill Ackman | Opened: 29-Apr-26, $24.00 | Priced: $30.00 | Underwriters: Lead: Citigroup, UBS Investment Bank, BofA Securities, Jefferies, Wells Fargo Securities |
Ends: 25-May-26 | Co: SBMT
Silver Bow Mining Corp (NYSE) | Early-stage mineral exploration company focused on silver and base metals projects in Montana | Opened: 30-Apr-26, $10.75 | Priced: $11.50 | Underwriters: Lead: Cantor, Research Capital USA Inc. |
Ends: 26-May-26 | Co: COAG
Hemab Therapeutics Holdings (Nasdaq) | Clinical-stage biotech developing antibody therapies for rare bleeding and clotting disorders | Opened: 01-May-26, $27.00 | Priced: $18.00 | Underwriters: Lead: Goldman Sachs & Co. LLC, Jefferies, Evercore ISI |
Ends: 26-May-26 | Co: SPTX
Seaport Therapeutics (Nasdaq) | Cinical-stage biotech company developing oral therapies for neuropsychiatric disorders using its proprietary Glyph platform to improve drug bioavailability and reduce side effects | Opened: 01-May-26, $21.00 | Priced: $18.00 | Underwriters: Lead: Goldman Sachs & Co. LLC, J.P. Morgan, Leerink Partners, Citigroup, Stifel |
